COVID-19
Showing NaN - NaN of 38
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo)
COVID-19 Trial in Puerto Rico, United States (Convalescent Plasma, Masked Saline Placebo)
Terminated
- COVID-19
- Convalescent Plasma
- Masked Saline Placebo
-
Birmingham, Alabama
- +23 more
Sep 9, 2022
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
COVID-19 Outcome Prediction Algorithm
Active, not recruiting
- COVID-19
- +4 more
- Blood and nasal swab sampling
-
Los Angeles, California
- +6 more
Jul 20, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
COVID-19 Trial in Worldwide (Dapagliflozin 10 milligram (mg), Placebo)
Completed
- COVID-19
- Dapagliflozin 10 milligram (mg)
- Placebo
-
Fairhope, Alabama
- +94 more
May 13, 2022
COVID-19, Coronavirus, Coronavirus Infection Trial in United States (Convalescent Plasma, Saline solution)
Active, not recruiting
- COVID-19
- +2 more
- Convalescent Plasma
- Saline solution
-
New Haven, Connecticut
- +8 more
Mar 30, 2022
COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)
Terminated
- COVID-19
- Apixaban 2.5 MG
- +3 more
-
Los Angeles, California
- +70 more
Feb 15, 2022